Skip to content

Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori, a multi-center RCT

Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori, a multi-center RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13004223
Enrollment
Unknown
Registered
2013-09-29
Start date
2014-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection

Interventions

Standard Quadruple Therapy:Hide susceptibility results, treatment for Clarithromycin–Amoxycillin-Containing Quadruple Therapy
Individualized Triple Therapy:Treatment for Clarithromycin–Amoxycillin-Containing Triple Therapy by culture with antimicrobial susceptibility
Individualized Quadruple Therapy:Treatment for Clarithromycin–Amoxycillin-Containing Triple Therapy by culture with antimicrobial susceptibility

Sponsors

Wenzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. aged 18~70 years old, Male or female, untreated patients; 2. symptoms of abdominal pain, bloating, acid reflux, belching, nausea, vomiting, heartburn, chest pain, vomiting, melena, etc; 3. unused antibiotics, bismuth, H2 receptor antagonists or PPI by Nearly 4 weeks; 4. (13)C-labelled urea breath test positive; 5. Agreed to Helicobacter pylori culture and sensitivity test taken by endoscopy gastric biopsy specimens, and the result of culture was positive; 6. Agreed to Helicobacter pylori eradication therapy and cooperate with the eradication efficacy follow-up survey.

Exclusion criteria

Exclusion criteria: 1. Severe heart, liver, kidney dysfunction; 2. Pregnant or lactating women; 3. Complications of bleeding, perforation, pyloric obstruction, cancer; 4. Esophageal,gastrointestinal surgery history; 5. Patients can not properly express their complaints,such as psychosis, severe neurosis; 6. Taking NSIAD or alcohol abusers; 7. Allergic to penicillin or either drugs of the 6 antibiotic tested by susceptibility testing.

Design outcomes

Primary

MeasureTime frame
Eradication rates;Compliance rate of Cultivation and eradication;The result of (13)C-labelled urea breath test;

Secondary

MeasureTime frame
The rate of culture positive result;

Countries

China

Contacts

Public ContactJie Pan

Wenzhou Central Hospital

panjie2002@gmail.com+86 13706658031

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026